Krishna Institute of Medical Sciences (KIMS) has announced a board meeting scheduled for November 7, 2025, to consider and approve the unaudited standalone and consolidated financial results for the second quarter (Q2) and half-year ending September 30, 2025.
Board to Review Q2 Financials
A meeting of the Board of Directors of Krishna Institute of Medical Sciences Limited will convene on Friday, November 07, 2025. The primary agenda is to review and approve the company’s financial performance for the period ending September 30, 2025.
Focus on Standalone and Consolidated Results
The board will specifically address both the standalone and consolidated unaudited financial results for the 02nd quarter (July-September) and half-year that concluded on September 30, 2025.
Trading Window Closure
In line with the company’s code of conduct, the trading window for dealing in the company’s equity shares has been closed for designated persons starting from October 01, 2025. The window will reopen 48 hours after the financial results are made public.
Source: BSE
